Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

  • Joshua Z Press1,
  • Alessandro De Luca2,
  • Niki Boyd2,
  • Sean Young2, 3,
  • Armelle Troussard2,
  • Yolanda Ridge3,
  • Pardeep Kaurah3,
  • Steve E Kalloger4,
  • Katherine A Blood2,
  • Margaret Smith5,
  • Paul T Spellman6,
  • Yuker Wang7,
  • Dianne M Miller8,
  • Doug Horsman2, 5,
  • Malek Faham7,
  • C Blake Gilks2, 4Email author,
  • Joe Gray6 and
  • David G Huntsman2, 3, 4
Contributed equally
BMC Cancer20088:17

DOI: 10.1186/1471-2407-8-17

Received: 24 July 2007

Accepted: 22 January 2008

Published: 22 January 2008

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
24 Jul 2007 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Aug 2007 Reviewed Reviewer Report - Amir Jazaeri
31 Aug 2007 Reviewed Reviewer Report - Kathleen Cho
1 Oct 2007 Author responded Author comments - Niki Boyd
Resubmission - Version 3
1 Oct 2007 Submitted Manuscript version 3
2 Oct 2007 Author responded Author comments - Niki Boyd
Resubmission - Version 4
2 Oct 2007 Submitted Manuscript version 4
15 Oct 2007 Reviewed Reviewer Report - Amir Jazaeri
3 Dec 2007 Author responded Author comments - Niki Boyd
Resubmission - Version 5
3 Dec 2007 Submitted Manuscript version 5
15 Jan 2008 Author responded Author comments - Niki Boyd
Resubmission - Version 6
15 Jan 2008 Submitted Manuscript version 6
Publishing
22 Jan 2008 Editorially accepted
22 Jan 2008 Article published 10.1186/1471-2407-8-17

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Obstetrics and Gynecology, University of British Columbia
(2)
Department of Pathology and Laboratory Medicine, University of British Columbia
(3)
Hereditary Cancer Program, British Columbia Cancer Agency
(4)
Genetic Pathology Evaluation Centre of the Prostate Centre, Vancouver General Hospital
(5)
Molecular Genetics, The Royal Melbourne Hospital
(6)
Life Sciences Division, Lawrence Berkeley National Laboratory, University of California
(7)
Affymetrix Inc
(8)
Department of Gynecologic Oncology, University of British Columbia

Advertisement